tiprankstipranks
Trending News
More News >
SRx Health Solutions (SRXH)
XASE:SRXH
US Market

SRx Health Solutions (SRXH) Ratios

Compare
222 Followers

SRx Health Solutions Ratios

SRXH's free cash flow for Q1 2026 was $0.38. For the 2026 fiscal year, SRXH's free cash flow was decreased by $ and operating cash flow was $-1.29. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
0.80 2.29 2.10 0.38 0.67
Quick Ratio
0.74 1.71 1.63 0.30 0.49
Cash Ratio
0.56 0.37 0.43 0.03 0.08
Solvency Ratio
-1.54 -5.63 >-0.01 -0.13 -0.05
Operating Cash Flow Ratio
-0.47 -2.23 -0.61 0.04 0.15
Short-Term Operating Cash Flow Coverage
-0.53 -375.57 -0.12 0.08 0.60
Net Current Asset Value
$ -4.69M$ 3.34M$ 7.85M$ -45.67M$ -19.06M
Leverage Ratios
Debt-to-Assets Ratio
0.78 0.74 2.87 0.61 0.51
Debt-to-Equity Ratio
5.97 15.33 -0.82 -6.26 19.25
Debt-to-Capital Ratio
0.86 0.94 -4.62 1.19 0.95
Long-Term Debt-to-Capital Ratio
0.00 0.94 -0.01 0.00 0.91
Financial Leverage Ratio
7.68 20.64 -0.29 -10.26 37.51
Debt Service Coverage Ratio
-1.60 -12.70 0.01 -0.20 -0.15
Interest Coverage Ratio
0.37 -13.16 -12.78 -2.83 -1.55
Debt to Market Cap
5.11 0.93 11.32 1.34 9.96
Interest Debt Per Share
0.73 0.34 28.34 3.34 26.42
Net Debt to EBITDA
-0.21 -0.38 96.44 -5.29 -30.02
Profitability Margins
Gross Profit Margin
20.11%22.88%36.77%19.85%14.36%
EBIT Margin
309.23%-176.46%0.88%-7.36%-1.26%
EBITDA Margin
282.81%-175.99%1.25%-5.93%-0.58%
Operating Profit Margin
-10.04%-176.46%-17.06%-4.88%-1.26%
Pretax Profit Margin
34.44%-132.22%-0.45%-9.20%-2.17%
Net Profit Margin
302.08%-688.80%-0.48%-9.36%-2.64%
Continuous Operations Profit Margin
27.45%-132.22%-0.48%-9.36%-2.64%
Net Income Per EBT
877.06%520.96%105.66%101.80%121.91%
EBT Per EBIT
-342.99%74.93%2.66%188.40%172.25%
Return on Assets (ROA)
-146.67%-535.66%-1.06%-17.27%-7.04%
Return on Equity (ROE)
435.85%-11057.99%0.30%177.08%-264.09%
Return on Capital Employed (ROCE)
37.43%-333.24%-68.96%586.03%-9.15%
Return on Invested Capital (ROIC)
5.37%-168.88%-12.52%-16.68%-6.04%
Return on Tangible Assets
-208.21%-535.66%-1.91%-30.73%-11.02%
Earnings Yield
-971.98%-672.64%-4.98%-43.02%-166.43%
Efficiency Ratios
Receivables Turnover
-4.30 1.19 4.52 16.85 27.41
Payables Turnover
-10.17 1.68 0.56 3.91 5.84
Inventory Turnover
-9.62 1.74 6.56 16.67 19.75
Fixed Asset Turnover
-179.93 43.38 2.79 11.18 12.59
Asset Turnover
-0.49 0.78 2.21 1.84 2.66
Working Capital Turnover Ratio
17.42 0.92 -2.15 -5.00 6.31
Cash Conversion Cycle
-86.97 300.40 -521.16 -49.73 -30.71
Days of Sales Outstanding
-84.92 307.35 80.79 21.66 13.32
Days of Inventory Outstanding
-37.95 209.92 55.60 21.90 18.48
Days of Payables Outstanding
-35.90 216.87 657.55 93.28 62.51
Operating Cycle
-122.87 517.27 136.39 43.56 31.79
Cash Flow Ratios
Operating Cash Flow Per Share
-0.33 -0.52 -2.70 0.23 4.80
Free Cash Flow Per Share
-0.33 -0.52 -2.72 0.13 4.45
CapEx Per Share
0.00 0.00 0.03 0.10 0.35
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 0.55 0.93
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 -106.27 2.24 13.81
Capital Expenditure Coverage Ratio
0.00 0.00 -106.27 2.24 13.81
Operating Cash Flow Coverage Ratio
-0.53 -1.76 -0.10 0.07 0.19
Operating Cash Flow to Sales Ratio
0.84 -1.68 -0.12 0.02 0.04
Free Cash Flow Yield
-268.65%-164.40%-130.26%6.09%212.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.10 -0.15 -20.10 -2.32 -0.60
Price-to-Sales (P/S) Ratio
-0.31 1.02 0.10 0.22 0.02
Price-to-Book (P/B) Ratio
1.16 16.44 -0.06 -4.12 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
-0.37 -0.61 -0.77 16.43 0.47
Price-to-Operating Cash Flow Ratio
-0.37 -0.61 -0.77 9.10 0.44
Price-to-Earnings Growth (PEG) Ratio
>-0.01 >-0.01 0.23 0.03 <0.01
Price-to-Fair Value
1.16 16.44 -0.06 -4.12 1.59
Enterprise Value Multiple
-0.33 -0.97 104.15 -8.96 -32.75
Enterprise Value
12.09M 11.10M 45.62M 63.21M 17.66M
EV to EBITDA
-0.33 -0.97 104.15 -8.96 -32.75
EV to Sales
-0.92 1.70 1.30 0.53 0.19
EV to Free Cash Flow
-1.09 -1.01 -10.37 40.12 5.64
EV to Operating Cash Flow
-1.09 -1.01 -10.47 22.21 5.23
Tangible Book Value Per Share
-0.13 0.02 0.77 -2.79 -16.53
Shareholders’ Equity Per Share
0.10 0.02 -34.12 -0.51 1.32
Tax and Other Ratios
Effective Tax Rate
-0.48 0.00 -0.06 -0.02 -0.22
Revenue Per Share
-0.39 0.31 21.65 9.60 131.54
Net Income Per Share
-1.18 -2.13 -0.10 -0.90 -3.48
Tax Burden
8.77 5.21 1.06 1.02 1.22
Interest Burden
0.11 0.75 -0.52 1.25 1.72
Research & Development to Revenue
0.00 0.00 <0.01 0.00 0.00
SG&A to Revenue
-2.76 0.00 0.00 0.22 0.14
Stock-Based Compensation to Revenue
<0.01 0.68 0.10 0.02 0.00
Income Quality
3.07 0.92 0.10 -0.26 -1.38
Currency in USD